Tell your surgical team you take it, and let them decide. That is not a hedge, it is the actual state of the guidance, and the reason is that professional recommendations shifted substantially between 2023 and 2024. Any article giving you a fixed number of days is describing one snapshot of a moving picture and cannot account for your dose, your symptoms, your other conditions, or the procedure you are having.<\/p>\n
What you can do is understand the concern and know what your team will be weighing.<\/p>\n
Semaglutide slows how quickly your stomach empties. That is central to how it works. It also means food can remain in your stomach longer than standard fasting rules assume.<\/p>\n
Under general anesthesia or deep sedation your protective airway reflexes are suppressed. If stomach contents come back up while those reflexes are off, they can enter the lungs. That is pulmonary aspiration, and it is uncommon but serious. Several published case reports of aspiration and regurgitation in fasted patients taking these medications are what prompted the professional bodies to act.<\/p>\n
The 2023 position.<\/strong> The American Society of Anesthesiologists issued consensus-based guidance in June 2023. For elective procedures it suggested considering holding daily-dosed GLP-1 medications on the day of the procedure, and weekly-dosed medications for a week beforehand, regardless of whether the indication was diabetes or weight loss. For urgent or emergency procedures, it advised treating the patient as having a full stomach and managing accordingly.<\/p>\n The 2024 shift.<\/strong> A multisociety clinical practice guidance was then published by the American Gastroenterological Association, the American Society for Metabolic and Bariatric Surgery, the International Society of Perioperative Care of Patients with Obesity, and the Society of American Gastrointestinal and Endoscopic Surgeons, with the ASA Administrative Council affirming its value. That document moved away from blanket holding toward risk stratification: therapy may be continued before a procedure in patients who do not have elevated risk of delayed gastric emptying and aspiration, with all patients still assessed on the day for symptoms suggesting retained stomach contents.<\/p>\n It also suggested that patients may benefit from a liquid diet for at least 24 hours beforehand, and it described itself explicitly as guidance rather than an evidence-based guideline, centered on shared decision-making.<\/p>\n Most importantly for anyone searching for a number: the guidance states that where holding is judged necessary, the appropriate duration is unknown.<\/p>\n That is why this article does not give you one.<\/p>\n The factors clinicians weigh include weekly rather than daily dosing, a dose that is currently being escalated, a higher dose, current gastrointestinal symptoms such as nausea, vomiting, bloating, or abdominal distension, and any other condition associated with slow gastric emptying, including diabetes with longstanding complications.<\/p>\n Consider this scenario: a patient on a stable maintenance dose for a year, with no gastrointestinal symptoms, having a short procedure with light sedation, is in a very different category from someone who increased their dose three weeks ago and has been nauseated since. Both take the same medication. A single rule covering both would be wrong for one of them.<\/p>\n Two errors are worth naming.<\/p>\n Do not stop on your own<\/strong> based on something you read. If you have diabetes, stopping has its own consequences for glucose control, and the guidance specifically flags that the risk of pausing differs between someone taking it for weight management and someone taking it for diabetes.<\/p>\n Do not conceal it<\/strong> because you are worried the procedure will be cancelled. Your anesthesia team can manage a known risk. They cannot manage one they do not know about, and the consequences of aspiration are considerably worse than a rescheduled operation.<\/p>\n Ask before you leave. The answer depends on how long you were held, what surgery you had, and how your recovery is going. If the gap runs longer than a couple of weeks, resuming at your previous dose is not automatic, since tolerance to gastrointestinal effects fades during a break. Our guide on taking a break from Ozempic and restarting<\/a> covers what that involves.<\/p>\n That is a different conversation with its own considerations, and it is worth having with the bariatric team rather than generalizing from procedures broadly. Our guides on Ozempic after weight loss surgery<\/a> and Ozempic versus surgery<\/a> cover how the two approaches interact.<\/p>\n You will not have the option to plan. Tell the team as soon as you can that you take this medication and when your last dose was. Guidance for urgent and emergency procedures is to proceed while managing the patient as though they have a full stomach, which means the team adjusts their technique rather than delaying necessary treatment.<\/p>\n Keeping this information somewhere accessible, on a medication list in your wallet or phone, is worth doing precisely because emergencies do not come with a pre-operative appointment.<\/p>\n Tell your surgical and anesthesia team, early and specifically, and let them set the plan. The guidance moved from blanket holding toward individual risk assessment, and the professional bodies themselves say the right hold duration is unknown. Report your symptoms honestly, ask about a liquid diet, get the instruction in writing, and ask about restarting before you leave.<\/p>\nWhat raises your risk in their assessment<\/h2>\n
What to actually do<\/h2>\n
\n
Do not decide this alone<\/h2>\n
Restarting afterward<\/h2>\n
If you are having weight loss surgery specifically<\/h2>\n
For emergency surgery<\/h2>\n
The short version<\/h2>\n